Article

Progress and challenges of mRNA vaccines

2022-12-22

Abstract excerpt

Abstract Messenger RNA (mRNA) vaccines are third‐generation nucleic acid vaccines developed after first‐generation inactivated and live‐attenuated vaccines and second‐generation subunit and viral vector vaccines, characterized by a rapid response to pathogen mutation, simple production process, and high production capacity. The basic mechanism through which mRNA vaccines provide immune protection is the introducti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6490501-50cd-5609-be67-43bb365f7bdb
DOI: 10.1002/inmd.20220008

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Progress and challenges of mRNA vaccinesDOI 10.1002/inmd.20220008Read

Development of mRNA Vaccines/Therapeutics and Their Delivery SystemSemantic proximity Read

Current Developments and Challenges of mRNA VaccinesSemantic proximity Read

The Delivery of mRNA Vaccines for TherapeuticsSemantic proximity Read

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read

mRNA-based modalities for infectious disease managementSemantic proximity Read

Recent Advances in mRNA Vaccine DevelopmentSemantic proximity Read

mRNA vaccines in the prevention and treatment of diseasesSemantic proximity Read

Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic VirusesSemantic proximity Read

mRNA Vaccine Technology Beyond COVID-19Semantic proximity Read

Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospectsSemantic proximity Read

mRNA vaccine development and applications: A special focus on tumors (Review)Semantic proximity Read

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read